UNSPSC 51112401: Amifostine monohydrate

This classification denotes a cytoprotective agent with the molecular formula C5H15N2O3PS.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L693H6MM64, chemically known as ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), monohydrate, but more generally known as amifostine monohydrate, which bears US NIH Compound Identifier 83996. European Medicines Agency schedules amifostine monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12846MIG.

Most nations, for tariff and trade purposes, schedule amifostine monohydrate under HS 29309085. SMILES: C(CN)CNCCSP(=O)(O)O.O.

UNSPSC 51112401 Amifostine monohydrate is a Commodity code covering a single pharmaceutical product — a cytoprotective agent used in cancer treatment to reduce certain chemotherapy and radiation side effects. The code reflects state and local procurement of this drug for use in hospital oncology departments, cancer treatment centers, and clinical settings where eligible patients receive qualifying chemotherapy or radiation regimens.

The source provides no recent state or local contract opportunities under this code. Without posted solicitations, issuing-body patterns, geographic concentration, or representative RFP, RFQ, IFB, or ITB activity to characterize, current market momentum under UNSPSC 51112401 cannot be assessed from available data.